Business Description
Sinotherapeutics Inc
ISIN : CNE100005PL9
Share Class Description:
SHSE:688247: Class ACompare
Compare
Traded in other countries / regions
688247.China IPO Date
2022-08-25Description
Sinotherapeutics Inc is engaged in the research and development, production and sales of generic drugs and CRO services.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7838.13 | |||||
| Equity-to-Asset | 0.88 | |||||
| Interest Coverage | 475.69 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 16.21 | |||||
| Beneish M-Score | -2.66 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 25.1 | |||||
| 3-Year EBITDA Growth Rate | 163.9 | |||||
| 3-Year EPS without NRI Growth Rate | 162.1 | |||||
| 3-Year Book Growth Rate | 41.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 76.27 | |||||
| 9-Day RSI | 64 | |||||
| 14-Day RSI | 58.47 | |||||
| 6-1 Month Momentum % | -26.34 | |||||
| 12-1 Month Momentum % | -48.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.25 | |||||
| Quick Ratio | 8.68 | |||||
| Cash Ratio | 7.64 | |||||
| Days Inventory | 127.91 | |||||
| Days Sales Outstanding | 65.13 | |||||
| Days Payable | 33.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.69 | |||||
| Dividend Payout Ratio | 0.4 | |||||
| Forward Dividend Yield % | 0.69 | |||||
| 5-Year Yield-on-Cost % | 0.69 | |||||
| 3-Year Average Share Buyback Ratio | 0.8 | |||||
| Shareholder Yield % | 0.79 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.59 | |||||
| Operating Margin % | 16.14 | |||||
| Net Margin % | 25.51 | |||||
| FCF Margin % | -18.96 | |||||
| ROE % | 5.95 | |||||
| ROA % | 5.25 | |||||
| ROIC % | 8.41 | |||||
| ROC (Joel Greenblatt) % | 25.54 | |||||
| ROCE % | 5.9 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 56.25 | |||||
| PE Ratio without NRI | 57.69 | |||||
| PS Ratio | 14.27 | |||||
| PB Ratio | 3.42 | |||||
| Price-to-Tangible-Book | 3.56 | |||||
| Price-to-Operating-Cash-Flow | 62.51 | |||||
| EV-to-EBIT | 43.5 | |||||
| EV-to-EBITDA | 43.5 | |||||
| EV-to-Revenue | 11.58 | |||||
| EV-to-FCF | -61.08 | |||||
| Price-to-Graham-Number | 3.02 | |||||
| Price-to-Net-Current-Asset-Value | 5.17 | |||||
| Price-to-Net-Cash | 6.52 | |||||
| Earnings Yield (Greenblatt) % | 2.3 | |||||
| FCF Yield % | -1.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinotherapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 274.023 | ||
| EPS (TTM) (Â¥) | 0.16 | ||
| Beta | 0 | ||
| Volatility % | 34.6 | ||
| 14-Day RSI | 58.47 | ||
| 14-Day ATR (Â¥) | 0.408427 | ||
| 20-Day SMA (Â¥) | 8.404 | ||
| 12-1 Month Momentum % | -48.81 | ||
| 52-Week Range (Â¥) | 6.3 - 16.67 | ||
| Shares Outstanding (Mil) | 453.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sinotherapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sinotherapeutics Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sinotherapeutics Inc Frequently Asked Questions
What is Sinotherapeutics Inc(SHSE:688247)'s stock price today?
The current price of SHSE:688247 is ¥9.00. The 52 week high of SHSE:688247 is ¥16.67 and 52 week low is ¥6.30.
When is next earnings date of Sinotherapeutics Inc(SHSE:688247)?
The next earnings date of Sinotherapeutics Inc(SHSE:688247) is .
Does Sinotherapeutics Inc(SHSE:688247) pay dividends? If so, how much?
The Dividend Yield %  of Sinotherapeutics Inc(SHSE:688247) is 0.69% (As of Today), Highest Dividend Payout Ratio of Sinotherapeutics Inc(SHSE:688247) was 0.4. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Sinotherapeutics Inc(SHSE:688247) is 0.69%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers